Macrogenics Inc (MGNX)
15.25
-0.83
(-5.16%)
USD |
NASDAQ |
Apr 19, 13:11
Macrogenics Enterprise Value: 774.10M for April 18, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 18, 2024 | 774.10M |
| April 17, 2024 | 775.35M |
| April 16, 2024 | 811.56M |
| April 15, 2024 | 827.79M |
| April 12, 2024 | 865.25M |
| April 11, 2024 | 925.81M |
| April 10, 2024 | 909.58M |
| April 09, 2024 | 900.21M |
| April 08, 2024 | 915.82M |
| April 05, 2024 | 908.95M |
| April 04, 2024 | 880.24M |
| April 03, 2024 | 623.64M |
| April 02, 2024 | 601.16M |
| April 01, 2024 | 645.49M |
| March 28, 2024 | 689.19M |
| March 27, 2024 | 704.18M |
| March 26, 2024 | 657.98M |
| March 25, 2024 | 669.84M |
| March 22, 2024 | 674.21M |
| March 21, 2024 | 731.02M |
| March 20, 2024 | 731.02M |
| March 19, 2024 | 742.89M |
| March 18, 2024 | 744.13M |
| March 15, 2024 | 764.74M |
| March 14, 2024 | 772.85M |
| Date | Value |
|---|---|
| March 13, 2024 | 804.07M |
| March 12, 2024 | 869.00M |
| March 11, 2024 | 827.79M |
| March 08, 2024 | 858.38M |
| March 07, 2024 | 1.051B |
| March 06, 2024 | 1.111B |
| March 05, 2024 | 1.059B |
| March 04, 2024 | 1.064B |
| March 01, 2024 | 960.15M |
| February 29, 2024 | 883.74M |
| February 28, 2024 | 837.19M |
| February 27, 2024 | 841.53M |
| February 26, 2024 | 813.60M |
| February 23, 2024 | 896.16M |
| February 22, 2024 | 832.22M |
| February 21, 2024 | 827.88M |
| February 20, 2024 | 835.95M |
| February 16, 2024 | 842.78M |
| February 15, 2024 | 850.22M |
| February 14, 2024 | 833.46M |
| February 13, 2024 | 847.12M |
| February 12, 2024 | 882.50M |
| February 09, 2024 | 845.26M |
| February 08, 2024 | 906.09M |
| February 07, 2024 | 852.09M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-45.99M
Minimum
Jun 16 2022
1.796B
Maximum
Apr 29 2021
557.51M
Average
384.50M
Median
Enterprise Value Benchmarks
| Allurion Technologies Inc | 98.22M |
| United Therapeutics Corp | 8.861B |
| MEI Pharma Inc | -37.83M |
| Heron Therapeutics Inc | 501.49M |
| Marinus Pharmaceuticals Inc | 0.1387M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -46.07M |
| Revenue (Quarterly) | 9.164M |
| Total Expenses (Quarterly) | 58.52M |
| EPS Diluted (Quarterly) | -0.75 |
| Gross Profit Margin (Quarterly) | 98.22% |
| Profit Margin (Quarterly) | -502.7% |
| Earnings Yield | -1.05% |
| Normalized Earnings Yield | -13.61 |